Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Synovial sarcoma
ADR ID BADD_A07738
ADR Hierarchy
15      Musculoskeletal and connective tissue disorders
15.09      Musculoskeletal and connective tissue neoplasms
15.09.03      Malignant musculoskeletal and connective tissue neoplasms
15.09.03.022      Synovial sarcoma
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.33      Soft tissue neoplasms malignant and unspecified
16.33.01      Soft tissue sarcomas histology unspecified
16.33.01.004      Synovial sarcoma
Description A malignant neoplasm arising from tenosynovial tissue of the joints and in synovial cells of tendons and bursae. The legs are the most common site, but the tumor can occur in the abdominal wall and other trunk muscles. There are two recognized types: the monophasic (characterized by sheaths of monotonous spindle cells) and the biphasic (characterized by slit-like spaces or clefts within the tumor, lined by cuboidal or tall columnar epithelial cells). These sarcomas occur most commonly in the second and fourth decades of life. (From Dorland, 27th ed; DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1363) [MeSH]
MedDRA Code 10042863
MeSH ID D013584
ADR Severity Grade (FAERS) Not Available
ADR Severity Grade (CTCAE) Not Available
Synonym
Synovial sarcoma | Synovial sarcoma non-metastatic | Synovial sarcoma NOS | Synovioma | Sarcoma, Synovial | Sarcomas, Synovial | Synovial Sarcoma | Synovial Sarcomas | Synoviomas
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01418Methotrexate--
BADD_D01687Pazopanib0.000448%
BADD_D02105Tacrolimus0.000446%
The 1th Page    1    Total 1 Pages